Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
detroit blog main
detroit top stories
life sciences
national blog main
national top stories
10
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
10
×
texas blog main
10
×
texas top stories
wisconsin blog main
10
×
wisconsin top stories
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
national
fda
cancer
deals
europe blog main
europe top stories
alzheimer's disease
cancer immunotherapy
gilead sciences
merck
novartis
pfizer
amag pharmaceuticals
What
roundup
bio
develop
life
sciences
acquisitions
amid
bombast
buy
cancer
caught
ceo
companies
coronavirus
covid
daniel
debate
debut
discussion
efforts
gilead
including
ipo
medicines
meso’s
miss
moves
new
o’day
pandemic
pfizer’s
presidential
promise
response
science
tuesday’s
vaccine
viewers
week
years
Language
unset
10
×
Current search:
startups
×
unset
×
" national top stories "
×
" wisconsin blog main "
×
" texas blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More